- A Shared Medical Appointment Intervention for Quality of Life Improvement in POTS
- A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS
- Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients
- Acute Salt Handling in Orthostatic Intolerance
- Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)
- Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome
- Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
- Autoimmune Basis for Postural Tachycardia Syndrome
- Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea
- Breathing Device in Postural Orthostatic Tachycardia Syndrome (POTS)
- Breathing Exercises With And Without Aerobic Training In Patients With Postural Orthostatic Tachycardia Syndrome
- Cardiovagal Baroreflex Deficits Impair Neurovascular Coupling and Cognition in POTS
- Cardiovascular Effects of Selective I(f)-Channel Blockade
- Compression Garments in the Community With POTS
- CRI in POTS in Adolescents
- Dietary Salt in Postural Tachycardia Syndrome
- Dietary Sodium’s Effect on Urinary Sodium and Dopamine Excretion in Patients With Postural Tachycardia Syndrome
- Effect of Ivabradine on Patients With Postural Orthostatic Tachycardia Syndrome
- Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
- Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS
- Gabapentin Treatment of Postural Tachycardia Syndrome (PoTS)
- Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
- Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
- High Sodium Diet and External Abdominal Compression in POTS
- Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)
- Iron Sucrose in Patients With Iron Deficiency and POTS
- Ivabradine for Long-Term Effects of COVID-19 With POTS Cohort
- Low Dose Naltrexone Use in Patients With POTS
- Paediatric Syncope in the Emergency Department
- Pathophysiology of Orthostatic Intolerance
- Physical Training in Patients With POTS After Covid-19
- Postural Sway and Counterpressure Maneuvers for Pediatric Syncope
- Postural Tachycardia Syndrome and Vasovagal Syncope in Relation to Serum Electrolytes and Adrenal Insufficiency
- Remote Self-training Program for Patients With Postural Orthostatic Tachycardia Syndrome
- The Effect of Physical Activity on Postural Orthostatic Tachycardia Syndrome
- The Long COVID-19 Wearable Device Study
- The Renin-Aldosterone Axis in Postural Tachycardia Syndrome
- Tilt Table With Suspected Postural Orthostatic Tachycardia Syndrome (POTS) Subjects
- Transdermal Vagal Stimulation for POTS
- Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome
Clinical Trials
- A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR)
- A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome
- A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
- A Phase 2/3 Study of RAD011 (Cannabidiol Oral Solution) for the Treatment of Patients With Prader-Willi Syndrome
- A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome
- A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
- A Study of GLWL-01 in Patients With Prader-Willi Syndrome
- A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
- A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Patients With Prader-Willi Syndrome
- A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome
- An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome
- An Open-Label Study of DCCR Tablet in Patients With PWS
- Assessment of CAI in Adults With PWS.
- Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project
- Bioequivalence of Two Somatropin Products (Norditropin® Versus Genotropin®) in Healthy Adult Volunteers
- Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS)
- Cannabidiol Oral Solution for the Treatment of Subjects With Prader-Willi Syndrome
- CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
- Characteristics of Prader-Willi Syndrome and Early-onset Morbid Obesity
- Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER)
- Characterization of Transcriptional Regulators of Ghrelin Hormone Which Causes Genetic Obesity
- Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome
- Comparative Study Between Prader-Willi Patients Who Take Oxytocin Versus Placebo
- Correlation of Hyperghrelinemia With Carotid Artery Intima-Media Thickness in Children With Prader-Willi Syndrome
- Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
- Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome
- Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome
- Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
- Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome
- Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
- Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome
- Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
- Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
- Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
- Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome
- Effects of Progressive Elastic Band Resistance Training
- Effects of Transcranial Direct Current Stimulation (tDCS) on Individuals With Prader-Willi Syndrome
- Evaluation of Tolerance, Suckling and Food Intake After Repeated Nasals Administrations of Oxytocin in PWS Infants
- Experience With Growth Hormone (GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the Pediatric Endocrine Department of the Hospital of Sabadell
- Exploring Stress and Coping Behaviors of the Major Carer Whose Children With Prader-Willi Syndrome
- Fiber Intervention on Gut Microbiota in Children With Prader-Willi Syndrome
- GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength and Body Composition
- Ghrelin Suppression by Octreotide in Prader-Willi
- Global Growth Hormone Study in Adults With Prader-Willi Syndrome
- Growth Hormone Use in Adults With Prader-Willi Syndrome
- Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
- Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
- Home-based SSP on Individuals With PWS
- Hypoglycemia in Prader-Willi Syndrome
- Improving Care of Prader-Willi Syndrome : Evaluation of a New Care Program Combining Adapted Physical Activity, Nutrition and Therapeutic Education
- Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome
- Intranasal Oxytocin for Infants With Prader-Willi Syndrome
- Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome
- Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
- Liraglutide Use in Prader-Willi Syndrome
- Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
- Macronutrient Regulation of Ghrelin and Peptide YY
- Mitochondrial Complex I Dysfunction in PWS
- Natural History Study of Serious Medical Events in PWS
- Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome
- Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
- Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome
- Open-Label Extension Study of Diazoxide Choline in Patients With Prader-Willi Syndrome
- Optimizing the Social Engagement System in Prader-Willi Syndrome: Insights From the Polyvagal Theory
- Oxygen Versus Medical Air for Treatment of CSA in Prader Will Syndrome
- Oxytocin Intranasal Administrations in Children With Prader-Willi Syndrome Aged From 3 to 12 Years
- Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome
- Oxytocin Trial in Prader-Willi Syndrome
- Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome
- Ph 2 Trial to Evaluate Safety & Efficacy of RM-493 in Obese Patients With Prader-Willi Syndrome
- Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
- Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome
- Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome
- Plasma Adiponectin Level and Vascular Endothelial and Smooth Muscle Cell Function in Children With Prader-Willi Syndrome
- Post Exercise Irisin Levels in PWS Patients
- Prader-Willi Syndrome and Appetite
- Prader-Willi Syndrome Body Composition
- Prader-Willi Syndrome Macronutrient Study
- PREPL in Health and Disease
- Probiotic Treatment for Prader-Willi Syndrome
- Proof of Concept Study of Vagus Nerve Stimulation
- PWS European Blood Bank for Infants and Controls From 0 to 48 Months
- PWS Outcomes Assessment Study
- Register of Patients With Prader-Willi Syndrome
- Retrospective Observational Study on Efficacy and Safety of Norditropin® in Children With Prader-Willi Syndrome
- Stress and Brain Response Using MEG in PWS
- Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation
- Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome
- Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS
- Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks
- Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
- Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome
- Targeting the Gut Microbiome for Prader-Willi Syndrome Treatment
- The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics
- The Intestinal Function in People With Prader-Willi Syndrome
- Therapeutic Effects of Hippotherapy in Children With Prader-Willi Syndrome
- Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies
- Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome
- tVNS in Children With Prader-Willi Syndrome
- Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome
- A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty
- A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China
- A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.
- Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate
- Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
- Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
- Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
- Effect of Exogenous Growth Hormone on Ocular Findings
- Effect of Prevalence of BMI on Efficacy of Herbal Medicines in Girls’ Sexual Precocity
- Effects of Triptorelin Pamoate in Children With Precocious Puberty – Follow up Study
- Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
- Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.
- Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
- Follicle-Stimulating Hormone (FSH) and the Onset of Puberty
- Follow-up of Girls With Premature Thelarche and Precocious Puberty
- Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
- Leuprorelin Acetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty
- LH Response to GnRH Test in Prepubescent Girls Under 6 Years
- Markers of Pubertal Suppression During Therapy for Precocious Puberty
- Overweight and Obesity and Puberty Development Cohort Study
- Purification of Testis-Stimulating Factor in Precocious Puberty
- Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty
- Study of Gonadotropin-Releasing Hormone Pulse Frequency in Sexual Maturation and in the Menstrual Cycle
- Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
- The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
- The Effect of Medical Clown on the Pain and Anxiety Perception During LRH Analog Treatment or GH Provocation Test
- The Genetic Investigation of Reproductive Disorders (Including Kallmann Syndrome)
- Age-related Hearing Loss and Lexical Disorders
- At-home Auditory Training Clinical Trial
- Computer-Based Auditory Rehabilitation
- Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
- Effects of Huperzine A on Presbycusis(Δ,kHz, dB,MMSE, AD)
- Efficacy and Safety of Liuwei Dihuang Pill Versus Placebo in Presbycusis With Shen (Kidney)-Yin Deficiency
- Evaluating Hearing Aid Service Delivery Models
- Evaluation of the Impact of Cochlear Implants on Cognition in Older Adults
- Impact of Auditory Stimulation in Eating Pleasure (EDERE 2021)
- Longitudinal Outcomes of Hearing Aids
- Mitochondrial Genetics of Presbycusis
- Predicting Success With Hearing Aids
- Study of the Association Between Presbycusis With the Incidence of Frailty
- Use of Hearing Aids. Development and Implementation of a Counselling Program for Hearing Aid Users
- Variability In Hearing Aid Outcomes In Older Adults
- 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism
- 68Ga-Pentixafor PET/CT for the Subtyping Diagnosis of Primary Aldosteronism: A Prospective Diagnostic Accuracy Study
- A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
- A Prospective Cohort Study for Patients With Adrenal Diseases
- A Prospective Randomised Trial Comparing Radiofrequency Ablation With Laparoscopic Adrenalectomy as an alternatiVE Treatment for Unilateral Asymmetric Primary Aldosteronism
- A Study of CIN-107 in Adults With Primary Aldosteronism
- Adrenal Artery Ablation for Primary Aldosteronism
- Adrenal Artery Ablation Treats Primary Aldosteronism
- Aldosterone Renin Ratio (ARR) Test to Increase Case-detection of Primary Aldosteronism (PA)
- AVS After 1mg DST to Determine Subtype in PA
- Calcium Channel Blockade in Primary Aldosteronism
- Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
- CETO First in Human Trial
- Chongqing Primary Aldosteronism Study
- Comparison of Three Confirmatory Tests in the Diagnosis of Primary Aldosteronism
- Diagnosing Variable Primary Aldosteronism.
- Diagnosis of Primary Aldosteronism: Comparison of Post Captopril Active Renin Concentration and Plasma Renin Activity
- Diagnostic Accuracy of Seated Saline Suppression Test for Primary Aldosteronism
- DP13 – A Phase II Study in Patients With Primary Aldosteronism
- Dynamic Hormone Diagnostics in Endocrine Disease
- Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism
- Effect of Anti-hypertensive Medications on the Diagnostic Accuracy in Screening for Primary Aldosteronism
- Effects of Adrenal Artery Ablation and Adrenalectomy in Patients With Primary Aldosteronism
- Effects of Adrenal Artery Ablation and Spironolactone in Patients With Primary Aldosteronism
- Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
- HyperAldosteronism in Pregnancy Predicted Impacts (H.A.P.P.I. Trial)
- Influence of Synacthen Infusion on the Results of Adrenal Venous Sampling in Patient With Primary Aldosteronism
- Intraoperative Analysis of Cortisol During Adrenal Vein Sampling
- Ipsilateral and Contralateral Index for the Interpretation of Adrenal Vein Sampling (AVS) in Primary Aldosteronism
- IS Metomidate PET-CT Superior to Adrenal Venous Sampling in Predicting Outcome From Adrenalectomy in Patients With Primary Hyperaldosteronism
- Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism
- Microvascular Function in Primary Aldosteronism
- Nuclear Imaging for Subtype Diagnosis of Primary Aldosteronism
- Open-label Study on Treatment of Primary Aldosteronism With Everolimus
- Optimizing Diagnosis Of Primary Aldosteronism
- Outcome of Patients With Primary Aldosteronism
- Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden Death
- Predicting Reduction of Hypertension After Adrenalectomy for Primary Aldosteronism: a Multicenter Analysis
- Preoperative Supine Time for Adrenal Venous Sampling
- Prevalence of Primary Aldosteronism Among Hypertensive Patients With Atrial Arythmia
- Prevalence of Primary Aldosteronism in Patients With Stroke
- Prevalence of Primary Aldosteronism in Young Adults With Acute Stroke
- Primary Aldosteronism and Surgically Curable Forms in Hypertension Patients Using 11C-Metomidate
- Primary Aldosteronism in General Practice: Organ Damage, Epidemiology and Treatment
- Primary Aldosteronism in Malaysia: A Nationwide Multicentre Study
- Primary Aldosteronism: Prospective Screening Registry in China
- Primary Hyperaldosteronism and Ischemia-reperfusion Injury
- Proof-of-concept for the Aldosterone Synthase Inhibitor LCI699 in Patients With Primary Hyperaldosteronism
- Prospective Evaluation of Confirmatory Testing For Primary Aldosteronism
- Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism
- Prospective Study on Primary Aldosteronism in Resistant Hypertension
- Radiofrequency Ablation for Aldosterone-producting Adenoma in Patients With Primary Aldosteronism
- Radiofrequency Endoscopic Ablation With Ultrasound Guidance: a Non-surgical Treatment for Aldosterone-producing Adenomas
- Renal Cysts and Primary Aldosteronism
- Screening for Primary Aldosteronism in a Population of Patients With Hypertension
- Study of CS-3150 in Patients With Primary Aldosteronism
- Study of Myocardial Interstitial Fibrosis in Hyperaldosteronism
- The Effect of Disease-specific Treatment on Bone Turnover Markers in Patients With Primary Aldosteronism
- The Effect of SAAE on Vascular Endothelial Function in PA Patients
- The Effect of SAAE on Ventricular Remodeling in PA Patients
- The Long-term Effect of SAAE and Medical Treatment for Primary Aldosteronism
- Tissue K+ in Primary Hyperaldosteronism
- A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients
- A Post-Authorisation Non-Interventional Observational of Patients in France With Primary Biliary Cholangitis Treated With Obeticholic Acid in Real Life
- A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome
- A Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
- A Study of Baricitinib (LY3009104) in Participants With Primary Biliary Cholangitis Who do Not Respond or Cannot Take UDCA
- A Study of Efficacy and Safety of Ustekinumab in Patients With Primary Biliary Cirrhosis (PBC) Who Had an Inadequate Response to Ursodeoxycholic Acid
- A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC)
- A Study to Assess Efficacy and Safety of Bezafibrate in Patients With Primary Biliary Cholangitis
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of EDP-305 in Subjects With Primary Biliary Cholangitis
- A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
- A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis
- A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
- An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
- An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis
- B-Cell Depleting Therapy (Rituximab) as a Treatment for Fatigue in Primary Biliary Cirrhosis
- Bezafibrate in Patients With Primary Biliary Cholangitis (PBC)
- Canadian Network for Autoimmune Liver Disease
- Clinical Research of Reducing Medication Regimen for Ursodeoxycholic Acid in Treatment of Stable Primary Biliary Cholangitis
- Clinical Trial on the Effect of the Sublimated Mare Milk Supplement on Primary Biliary Cholangitis
- Combination Antiretroviral Therapy (cART) for PBC
- Development of Ursodeoxycholic Acid 300 mg at Hospital Das Clinicas of the University of São Paulo School of Medicine
- Early Identification of Myocardial Impairment in PBC
- Effect of Obeticholic Acid on Transport of Bile Acids in PBC Examined by 11C-cholyl-sarcosine PET/CT
- Effectiveness of S-adenosyl-L-methionine in Patients With Primary Biliary Cirrhosis
- Efficacy and Safety of Fenofibrate Combined With UDCA in PBC Patients With an Incomplete Biochemical Response to UDCA
- Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
- Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis
- ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)
- Equitable Mental Wellness Programming for Older Adults With Chronic Physical Conditions
- EXerCise Intervention in cholesTatic LivEr Disease: The EXCITED Study
- Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
- Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
- Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid
- Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis
- Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
- Fuzhenghuayu for Patients With PBC Who Had An Inadequate Response to Ursodeoxycholic Acid
- Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis
- Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
- Gut Microbes and Metabolic Group in Different PBC Patients for UDCA Response
- High-protein High-fiber Diet in Patients With Primary Biliary Cirrhosis
- Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis
- Identification of Inflammatory and Fibrotic Biomarkers in PBC and NAFLD Patients
- Initial Study of Rituximab to Treat Primary Biliary Cirrhosis
- Mesenchymal Stem Cell Transplantation for Refractory Primary Biliary Cholangitis
- Mind-body Wellness Intervention in Primary Biliary Cholangitis (PBC)
- Mindfulness – Based Intervention in the Treatment of Fatigue in Patients With Primary Biliary Cholangitis
- Modafinil in the Treatment of Fatigue in Patients With Primary Biliary Cirrhosis (PBC)
- Moexipril for Primary Biliary Cirrhosis
- Mycophenolate Mofetil Versus Cyclosporin A in the Treatment of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome Due to Nonresponse to Standard Therapy
- Nalfurafine Hydrochloride for Pruritus in Patients With Primary Biliary Cholangitis
- National Database on Primary Biliary Cholangitis
- Online Wellness Intervention for Primary Biliary Cholangitis (PBC)
- Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis
- Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis
- PBC Induced Fatigue Treated With Thiamine
- Pentoxifylline for Primary Biliary Cirrhosis
- Performance of Scoring Systems in Chinese Patients With Primary Biliary Cholangitis (PBC) on Ursodeoxycholic Acid
- Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
- Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Subjects With Primary Biliary Cirrhosis
- Phase 2 Study to Evaluate LUM001 in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cirrhosis
- Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
- Phase 3 Study of Obeticholic Acid in Patients With Primary Biliary Cirrhosis
- Pilot Study of FFP104 Dose Escalation in PBC Subjects
- Primary Biliary Cirrhosis: Investigating A New Treatment Option Using NI-0801, an Anti-CXCL10 Monoclonal Antibody
- Probiotics in PBC Patients of Poor Response to UDCA
- Prospective, Multicenter Cohort Study on Primary Biliary Cholangitis
- Real-World Data Study to Evaluate the Effectiveness of OCA on Hepatic Outcomes in PBC Patients
- RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)
- Safety and Efficacy of Long-Term Treatment With Atorvastatin in Patients With Primary Biliary Cirrhosis
- Safety and Efficacy of Tauroursodeoxycholic Acid Versus Ursofalk in the Treatment of Adult Primary Biliary Cirrhosis
- Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I)
- Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Biliary Cholangitis Without Cirrhosis
- Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis
- Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis
- sCD163 in PBC Patients – Assessment of Disease Severity and Prognosis
- sCD163 in PBC Patients – Assessment of Treatment Response
- Seladelpar (MBX-8025) in Subjects With Primary Biliary Cholangitis (PBC)
- Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
- Stem Cell Transplantation in Patients With Primary Biliary Cirrhosis
- Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
- Study of Abatacept (Orencia) to Treat Primary Biliary Cirrhosis
- Study of Combivir for Patients With Primary Biliary Cirrhosis
- Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid
- Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
- Study of Obeticholic Acid（OCA） Combination With Ursodeoxycholic Acid (UDCA) in Patients With Primay Biliary Cirrhosis (PBC)
- Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Patients With PBC
- Study to Assess Safety and Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid.
- Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis
- Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS0159 in Chinese Healthy Subjects
- Study to Evaluate the Effects of Two Doses of MBX-8025 in Subjects With Primary Biliary Cirrhosis (PBC)
- Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid
- Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis
- Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
- The Comparison About the Response of Ursodeoxycholic Acid in Primary Biliary Cholangitis Only and Primary Biliary Cholangitis With High Immune Globulin G or Aminotransferase at West China Hospital
- The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
- Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia
- Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
- Ursodeoxycholic Acid Combined With Low Dose Glucocorticoid in the Treatment of PBC With AIH Features II
- Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
- Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
- Use of Bezafibrate in Patients With Primary Biliary Cirrhosis to Archive Complete Biochemical Response in Non-responders
- Use of Fenofibrate for Primary Biliary Cirrhosis
- A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
- COVID-19 in People With Primary Ciliary Dyskinesia
- Evaluation of the Safety of the Medical Device Simeox®
- Functional Studies of Novel Genes Mutated in Primary Ciliary Dyskinesia II: Genotype to Phenotype
- Intervention in Chronic Pediatric Patients and Their Families.
- Physiological Responses to Exercise Tests in Primary Ciliary Dyskinesia Compared With Healthy Individuals
- Respiratory Physiotherapy Performed by Simeox In Patients With Primary Ciliary Dyskinesia
- Study Evaluating the Safety and Tolerability of RCT1100 in Healthy Subjects
- The Effect of a Dietary Supplement Rich in Nitric Oxide in Patients Diagnosed With Primary Ciliary Dyskinesia.
- Upper Extremity Exercise Capacity, Muscle Oxygenation, Balance in Patients With Primary Ciliary Dyskinesia
- Use of Nasal Nitric Oxide Testing in Improving Primary Ciliary Dyskinesia Clinical Care
- Utilizing Hyperpolarized 129Xe Magnetic Resonance Imaging in Children With Primary Ciliary Dyskinesia
- Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis
- Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
- Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
- Pegylated Liposomal Doxorubicin (Doxil) With Rituximab in Relapsed AIDS-Related Non-Hodgkin’s Lymphomas
- Specimen Collections From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas
- Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas
- A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
- A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1
- A Study to Evaluate Lumasiran in Children and Adults With Primary Hyperoxaluria Type 1
- A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1
- A Study to Evaluate the Efficacy and Safety of Oxabact in Patients With Primary Hyperoxaluria
- An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Patients With Primary Hyperoxaluria Type 1
- BONAPH1DE, A Prospective Observational Study of Patients With Primary Hyperoxaluria Type 1 (PH1)
- Evaluation of the Efficacy of Stiripentol (Diacomit) as Monotherapy for the Treatment of Primary Hyperoxaluria
- Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1
- Health-related Quality of Life in Rare Kidney Stone
- IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA
- Natural History of Patients With PH3 and a History of Stone Events
- Phase 2/3 Oxabact Study
- Phenotyping of Primary Hyperoxaluria
- Primary Hyperoxaluria Mutation Genotyping
- Primary Hyperoxaluria Mutation Genotyping/Phenotyping
- Proteomics of Primary Hyperoxaluria Type 1
- Rare Kidney Stone Consortium Patient Registry
- Study of ALLN-177 in Patients Aged 12 Years or Older With Enteric or Primary Hyperoxaluria and Hyperoxalemia
- Study of DCR-PHXC-101 in Normal Healthy Volunteers and Patients With Primary Hyperoxaluria
- Study of Lumasiran in Healthy Adults and Patients With Primary Hyperoxaluria Type 1
- Study to Evaluate Safety, Tolerability, PK and PD of DCR-PHXC in PH Type 3 Patients
- Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
- Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis
- Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients
- Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate
- A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2
- International Registry for Primary Hyperoxaluria
- Long Term Extension Study in Patients With Primary Hyperoxaluria
- Nedosiran in Pediatric Patients From Birth to 5 Years of Age With PH and Relatively Intact Renal Function
- Rare Kidney Stone Consortium Biobank
- Safety & Efficacy of DCR-PHXC in Patients With PH1/2 and ESRD
- A Prospective Monocentric Study to Assess the Concordance of Lung MRI Compared to Chest CT Scan to Assess the Extent and Severity of Bronchial and Parenchymal Pulmonary Lesions in Adult Patients With Primary Immune Deficiency (PID) .
- A Study About Low Blood Pressure in Patients With Primary Immunodeficiency Disease Treated With Immune Globulin Products
- A Study to Compare Quality of Life and Satisfaction in Primary Immunodeficient Patients Treated With Subcutaneous Injections of Gammanorm® 165 mg/mL Administered With Two Different Delivery Devices: Injections Using Pump or Rapid Push
- A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency
- A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Immune Globulin (Human) 10% (Gamunex-C) PEG Process (IVIG-PEG) Compared to Gamunex-C in Participants With Primary Humoral Immunodeficiency
- Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
- Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
- An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease
- An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
- ASIS for GAMMAGARD in Primary Immunodeficiency
- Bilateral Orthotopic Lung Transplant – Bone Marrow Transplant
- CD34+ Stem Cell Infusion to Augment Graft Function
- Clinical and Laboratory Online Patient- and Research Database for Primary Immunodeficiencies in Switzerland
- Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)
- COVID-19 in PID Survey
- COVID-19 Vaccine in Patients After Allogeneic HCT, CAR-T Therapy and With Primary Immune Deficiency
- Determinants of Health Status and Quality of Life in Patients With Primary Immunodeficiencies Inhereted Diagnosed During Childhood
- Developing a Screening Tool for Primary Immunodeficiency Disease (PID) in Pakistan
- EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
- Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
- Efficacy, Pharmacokinetics, Safety, and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency
- Evaluation of an IgG Deficiency Rapid Screening Test: A Performance Study With Primary Immunodeficiency (PID) Patients in Tunisia
- Evaluation of Efficacy and Tolerability of Hizentra®
- Evaluation of the Efficacy of the Sequencing Method by Gene-panel
- Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)
- Facilitated Immunoglobulin Administration Registry and Outcomes Study (FIGARO)
- Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)
- Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
- Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps
- High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam)
- Identification of New Inborn Errors of Immunity
- Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)
- IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia
- Immunological Characteristics of Patients With PID and IBD
- Intensive Care Unit and Secondary and Primary Immune Deficiency
- Investigation of Dental Health in Children With Neutrophil Defects: A Clinical Study
- Investigation of Immune Disorders and Deficiencies
- Minipooled-IVIG in Primary Immunodeficiency Disease
- Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)
- NIAID Centralized Sequencing Protocol
- Octagam 5% Versus Comparator Post Marketing Trial
- Open Label, Phase III Study of NABI-IGIV 10% [Immune Globulin Intravenous(Human), 10%] In Subjects With Primary Immune Deficiency Disorders (PIDD)
- Pathophysiology of Inborn Immunodeficiencies
- Pediatric Primary Immunodeficiency Disease (PID) in China
- Pharmacokinetics and Safety of IVIG Nanogam 100 mg/ml
- Pharmacokinetics, Safety, and Tolerability of Subcutaneous GAMUNEX-C in Pediatric Subjects With Primary Immunodeficiency
- Primary Immunodeficiencies in Costa Rican Adults
- Primary Immunodeficiency in Kuwait
- Primitive Immunodeficiency and Pregnancy
- Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide
- Retrospective Chart Review of Subcutaneous IgG Use in Infants
- Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency
- Safety and Tolerability of Higher Infusion Parameters of IgPro20 (Hizentra) in Subjects With Primary Immunodeficiency (PID)
- Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency
- Safety, Tolerability, Patient Satisfaction and Cost of 16.5% Subcutaneous Immunoglobulin (Cutaquig®) Treatment
- Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
- Send-In Sample Collection to Achieve Genetic and Immunologic Characterization of Primary Immunodeficiencies
- Severe Immune Cytopenia Registry Www.Sic-reg.Org
- Study Evaluating IGSC 20% Flexible Dosing in Treatment-Experienced and Treatment-Naive Subjects With Primary Immunodeficiency
- Study of Gut Microbiota in Primary Immune Deficiency, Possibly Associated With Inflammatory Bowel Disease
- Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
- Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency
- Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
- Study of Octanorm Subcutaneous IG in Patients With PID
- Study of Octanorm Subcutaneous IG in Patients With Primary Immunodeficiency Diseases Who Have Completed the SCGAM-01 Trial
- Study of ProMetic BioTherapeutics Immune Globulin Intravenous (Human) 10%
- Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (EU Extension Study)
- Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)
- Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy
- Study of Vitamin D3 Substitution to Patients With Primary Immunodeficiency
- Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases
- Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases
- Study to Monitor the Safety, Tolerability and Efficacy of Subcutaneous Human Immunoglobulin (Octanorm) in Patients With Primary Immunodeficiency Diseases, Including (But Not Limited to) Those Who Have Completed the SCGAM-01 Trial
- Subcutaneous Ig NextGen 16% in PID Patients
- Systematic Screening for Primary Immunodeficiencies in Patients Hospitalized for Severe Infections in Intensive Care.
- TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
- TCR Alpha/Beta and CD19 TCD in HCT for Patients With Hematological Malignancies and Nonmalignant Disorders
- TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID
- The Benefit of 5% IVIG for Patients With Primary Immunodeficiency Disorders Who Experience Adverse Events on 10% IVIG Preparations
- The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease
- Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)
- Treosulfan-based Versus Busulfan-based Conditioning in Paediatric Patients With Non-malignant Diseases
- Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
- What is the Incidence of an Immune Disorder in Children With Invasive Pneumococcal Disease (IPD)?